Both Vanderbilt Medical Center and Williamson Medical Center have joined the Healthcare Worker Exposure Response and Outcomes (HERO) clinical trial, a federally-supported research effort investigating the effectiveness of plaquenil hydroxychloroquine in preventing the contraction of COVID-19. Sponsored by Duke University and in collaboration with the Patient-Centered Outcomes Research Institute (PCORI), the investigators hope to determine if the experimental treatment can help prevent the virus.
Vanderbilt & Williamson Medical Center of TN Join HERO Study
Interested in Enrolling?
If you are interested in learning more about a clinical trial, please click on enroll now and provide your information. Our staff will be happy to contact you to provide additional details and determine if you are suitable to participate in one of our active clinical trials. There is no obligation, and your information will be kept confidential.